Retraction: Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by Norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway

Abstract

Full text

After this article [1] was published, concerns were raised regarding results presented in Figs 2, 3, 6, and 7.

Specifically

The authors did not respond to editorial requests for a response and underlying data. In light of the above unresolved concerns that question the integrity and reliability of the reported results and conclusions, the PLOS One Editors retract this article.

All authors either did not respond directly or could not be reached.